135 related articles for article (PubMed ID: 17171440)
1. Intravascular cell-to-cell adhesive interactions and bone metastasis.
Glinsky VV
Cancer Metastasis Rev; 2006 Dec; 25(4):531-40. PubMed ID: 17171440
[TBL] [Abstract][Full Text] [Related]
2. Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium.
Glinsky VV; Glinsky GV; Glinskii OV; Huxley VH; Turk JR; Mossine VV; Deutscher SL; Pienta KJ; Quinn TP
Cancer Res; 2003 Jul; 63(13):3805-11. PubMed ID: 12839977
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow cells in the 'pre-metastatic niche': within bone and beyond.
Kaplan RN; Psaila B; Lyden D
Cancer Metastasis Rev; 2006 Dec; 25(4):521-9. PubMed ID: 17186383
[TBL] [Abstract][Full Text] [Related]
4. Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases.
Siclari VA; Guise TA; Chirgwin JM
Cancer Metastasis Rev; 2006 Dec; 25(4):621-33. PubMed ID: 17165131
[TBL] [Abstract][Full Text] [Related]
5. The bone microenvironment in metastasis; what is special about bone?
Bussard KM; Gay CV; Mastro AM
Cancer Metastasis Rev; 2008 Mar; 27(1):41-55. PubMed ID: 18071636
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between cancer cells and bone microenvironment in bone metastasis.
Yoneda T; Hiraga T
Biochem Biophys Res Commun; 2005 Mar; 328(3):679-87. PubMed ID: 15694401
[TBL] [Abstract][Full Text] [Related]
7. Tumor metastasis to bone.
Virk MS; Lieberman JR
Arthritis Res Ther; 2007; 9 Suppl 1(Suppl 1):S5. PubMed ID: 17634144
[TBL] [Abstract][Full Text] [Related]
8. The molecular basis of skeletal metastases.
Choong PF
Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S19-31. PubMed ID: 14600589
[TBL] [Abstract][Full Text] [Related]
9. The role of adhesive proteins in the hematogenous spread of cancer.
Zhou J; Sargiannidou I; Tuszynski GP
In Vivo; 2000; 14(1):199-208. PubMed ID: 10757078
[TBL] [Abstract][Full Text] [Related]
10. Bone metastasis in prostate cancer: molecular and cellular mechanisms (Review).
Ye L; Kynaston HG; Jiang WG
Int J Mol Med; 2007 Jul; 20(1):103-11. PubMed ID: 17549396
[TBL] [Abstract][Full Text] [Related]
11. Biochemical approach to the detection and monitoring of metastatic bone disease: What do we know and what questions need answers?
Tankó LB; Karsdal MA; Christiansen C; Leeming DJ
Cancer Metastasis Rev; 2006 Dec; 25(4):659-68. PubMed ID: 17160557
[TBL] [Abstract][Full Text] [Related]
12. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis.
Yee AJ; Akens M; Yang BL; Finkelstein J; Zheng PS; Deng Z; Yang B
Breast Cancer Res; 2007; 9(4):R47. PubMed ID: 17662123
[TBL] [Abstract][Full Text] [Related]
13. Cadherin-11-mediated interactions with bone marrow stromal/osteoblastic cells support selective colonization of breast cancer cells in bone.
Tamura D; Hiraga T; Myoui A; Yoshikawa H; Yoneda T
Int J Oncol; 2008 Jul; 33(1):17-24. PubMed ID: 18575746
[TBL] [Abstract][Full Text] [Related]
14. Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis.
Bonfil RD; Chinni S; Fridman R; Kim HR; Cher ML
Urol Oncol; 2007; 25(5):407-11. PubMed ID: 17826661
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms and treatment of bone metastasis.
Clines GA; Guise TA
Expert Rev Mol Med; 2008 Mar; 10():e7. PubMed ID: 18321396
[TBL] [Abstract][Full Text] [Related]
16. Platelets and cancer metastasis: more than an epiphenomenon.
Honn KV; Tang DG; Chen YQ
Semin Thromb Hemost; 1992; 18(4):392-415. PubMed ID: 1470927
[TBL] [Abstract][Full Text] [Related]
17. A novel model of bone-metastatic prostate cancer in immunocompetent mice.
Power CA; Pwint H; Chan J; Cho J; Yu Y; Walsh W; Russell PJ
Prostate; 2009 Nov; 69(15):1613-23. PubMed ID: 19585491
[TBL] [Abstract][Full Text] [Related]
18. Kallikrein 4 is a potential mediator of cellular interactions between cancer cells and osteoblasts in metastatic prostate cancer.
Gao J; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
Prostate; 2007 Mar; 67(4):348-60. PubMed ID: 17221837
[TBL] [Abstract][Full Text] [Related]
19. Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model.
Moreau JE; Anderson K; Mauney JR; Nguyen T; Kaplan DL; Rosenblatt M
Cancer Res; 2007 Nov; 67(21):10304-8. PubMed ID: 17974972
[TBL] [Abstract][Full Text] [Related]
20. Current trials using bone-targeting agents in prostate cancer.
Tu SM; Lin SH
Cancer J; 2008; 14(1):35-9. PubMed ID: 18303481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
